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Greenberg et al., 1998). Although the mouse is a good histopathological findings in the aged balding G3 and
G6 mice are consistent with a diagnosis of androgeneticmodel for studying telomerase activity and its regulation,
the long telomeres in this species, despite modest attri- alopecia (male pattern baldness; Courtois et al., 1994).
In addition to changes in hair number and color, a highertion with aging (K. L. R. and R. A. D., unpublished data),
make it unlikely that telomere length plays a prominent incidence of severe ulcerative skin lesions were seen in
G3 and G6 mice 15 months and older compared torole in normal mouse aging.
A critical evaluation of the effect of telomere shorten- mTR1/1 animals (Figures 1D, 1G, and 1H). While the fre-
quency of skin lesions in G3 and G6 animals is similar,ing on aging in vivo has been hampered by the lack of
mammalian-based model systems. We have previously the onset of skin ulcerations was earlier in life in G6
compared to mTR1/1 and G3 animals (average age: 25generated telomerase-deficient mice through disruption
of the gene encoding the essential RNA component of months in mTR1/1, 26 months in G3, and 15 months
in G6). These lesions were located predominantly atthe telomerase holoenzyme (mTR) (Blasco et al., 1997).
These studies established that mTR2/2 mice exhibit pro- anatomical sites that are exposed to chronic mechanical
stress, including distal limbs, perineum, snout, andgressive telomere shortening with each successive gen-
eration arising from mTR2/2 intercrosses (Blasco et al., throat area. Histologically, the skin lesions appeared as
ulcerations with epidermal hyperplasia, hyperkeratosis,1997; Lee et al. 1998). Sixth generation mice (G6) were
infertile, had a decreased proliferative capacity of sple- and underlying dermal fibrosis (Figure 1I). Such lesions
are similar to those seen after chronic superficial trauma,nocytes and bone marrow cells in vivo, and had an
increased embryonic lethality due to neural tube closure particularly in debilitated elderly humans.
defects (Lee et al., 1998; Herrera et al., 1999). Third
generation mTR2/2 mice (G3) possess shortened telo-
Telomere Length Correlates Inverselymeres early in life but, at this point, appear to be pheno-
to the Incidence of Skin Lesion,typically normal in every respect (Lee et al., 1998). The
Alopecia, and Hair Grayingcurrent study focused primarily on the physiological
To determine whether telomere shortening played aconsequences in an aging population of G3 mice and
causal role in the skin phenotypes described above, telo-compared these results to first and sixth generation
mere length analysis was performed on G3 mice of dif-mTR2/2 mice (G1 and G6, respectively) to dissect the
ferent ages. Quantitative (Q)-FISH is a powerful methodcontribution of telomere dysfunction to the pathophysio-
to determine telomere length in mice. Using this method,logical processes and events associated with aging.
it was shown that telomere length decreases at a rate
of 4–5 kb/generation in mTR null mice (Blasco et al.,
Results 1997). A newly developed flow cytometry fluorescence
in situ hybridization (flow-FISH) method (Hultdin et al.,
To assess the effect of progressive telomere loss on mice 1998; Rufer et al., 1998) yielded very similar measure-
with increased age, we studied a cohort of mice over a ments of relative telomere length in successive mTR
2.5 year period. Specifically, 63 mTR1/1, 35 mTR2/2 G1, null MEF cultures (Figure 2A; Greenberg and R. A. D.,
35 mTR2/2 G3, and 36 mTR2/2 G6 mice were analyzed unpublished data) and showed comparable results for
for a broad spectrum of phenotypes associated with different cell types within a given generation of mTR2/2
the aging process. For brevity, we refer to successive mice (MEFs and peripheral blood leukocytes, data not
generations of telomerase-deficient mice as G1 (for G1 shown). Flow-FISH allows the determination of telomere
mTR2/2), G2 (for G2 mTR2/2), and so on. length in a large number of samples and can be per-
formed on primary cells derived from peripheral bleeds.
Since young G3 mice are phenotypically normal but pro-Hair Graying, Alopecia, and Skin Lesions
A dramatic increase in the incidence of hair graying and gressively experience age-dependent compromise in
the skin, flow-FISH telomere length determinations werealopecia (hair loss) was noted in aging G3 and G6 mice
compared to age-matched mTR1/1 mice (Figures 1A–1D: obtained in leukocytes derived from multiple 1-month-
old and .16-month-old G3 mice. A .50% reduction in25% in mTR1/1, 54% in G3, and 60% in G6, in animals
older than 15 months). In addition, hair graying was telomere length was observed in old G3 samples relative
to young G3 samples (Figure 2B, p 5 0.035), a findingseen at younger ages: some of the G6 animals showed
graying at 6 months of age, while none of the G3 or consistent with the view that cell proliferation-depen-
dent telomere erosion takes place in highly proliferativemTR1/1 mice showed alopecia or hair graying at this
age. Hair growth is a cyclic process in which the hair organ systems during life.
Next, we addressed whether differences in telomerefollicle progresses through an active growth phase (ana-
gen), an involuting phase (catagen), and a resting phase length correlate with the presence or absence of age-
associated cutaneous phenotypes in aged G3 mice. The(telogen) (Courtois et al., 1995). Dorsal skin specimens
from 15- to 18-month-old G3 and G6 mice showed equal relative telomere fluorescence signal of disease-free G3
mice was approximately 3-fold higher than in age-numbers of hair follicles in the dermis compared to
mTR1/1 animals (Figures 1E and 1F), but there was a matched G3 mice afflicted with ulcerative skin lesions,
hair graying, and alopecia (Figure 2C; comparing sixclear increase in miniaturized, involuted, melanin-rich
follicles in the superficial dermis (Figure 1F). The number animals with ulcerative skin lesions/hair graying or alo-
pecia to five age-matched, disease-free animals, p 5of hair follicles in the growth phase (anagen) relative to
the resting phase was 2- to 3-fold lower in G3 and G6 0.029). These data suggest that animals with shorter
telomeres are more likely to display a disease phenotypecompared to mTR1/1 animals (Figures 1E and 1F). These
Aging in the Telomerase Null Mouse
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Figure 1. Increased Incidence of Skin Lesions, Alopecia, and Hair Graying in Aging mTR2/2 Mice
(A–C) Representative examples of alopecia and hair graying in mTR1/1 and mTR2/2 mice.
(D) Incidence of ulcerative skin lesions and hair graying/alopecia in aged mTR1/1, G3, and G6 mice.
(E and F) Histologic appearance of representative H&E-stained skin sections from a 21-month-old mTR1/1 mouse and a 17-month-old G6
mouse. Compared to the mTR1/1 skin, in which nearly all hair follicles are in anagen (A, arrow), the G6 skin exhibited an increased frequency
of hair follicles in telogen (T, arrows). In G6 skin, the subcutaneous fat cell layer (FCL) was replaced by dense, fibrous tissue (asterisk; 103
objective).
(G–H). Perioral, neck, and hind limb ulcerative skin lesions in G3 and G6 mice.
(I) H&E-stained section of an area of chronic injury in the vicinity of an ulcerative skin lesion in an 18-month-old G3 mouse (403 objective)
showing marked epidermal hyperplasia (#), hyperkeratosis (arrow), and a dense dermal fibrosis (*).
in the skin, further suggesting that telomere shortening the functional metabolic and structural integrity of many
organ systems was also normal (data not shown). More-in vivo contributes to disease susceptibility.
over, radiographic and histologic analyses of the femur
failed to demonstrate osteoporosis, histological exami-Telomere Shortening Does Not Cause Generalized
Premature Aging nation of aged arterial walls did not reveal signs of arte-
riosclerosis, and cataract formation occurred at similarTo determine whether other phenotypes often associ-
ated with aging occur early in the aging G3 animals, we frequencies in all groups (data not shown). Normal blood
glucose levels after fasting and in response to glucosecarried out a broad histological survey of many organ
systems (see Table 1). Analysis of the cardiovascular challenge showed that glucose tolerance was normal
in these mice (data not shown). With the exception ofsystem, liver, kidneys, and brain showed no pathological
changes typical of aging organisms (data not shown). modest reduction in spleen size, telomere shortening
did not result in significant defects in the cellularity andA comprehensive serum chemistry profile that surveys
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Figure 2. Telomere Length Decreases with Increasing Age and Correlates with the Skin Phenotype
(A) Relative telomere length of mouse embryo fibroblasts (MEF) derived from mTR1/1, G4, and G6 mice, comparing data obtained by flow-
FISH and Q-FISH analysis (Greenberg and R. A. D., unpublished data). Fluorescence intensities of mTR1/1 cells were set at 100%, and the
relative intensity of G4 and G6 cells was calculated.
(B) Relative telomere length of peripheral WBC of 1-month-old and .16-month-old G3 mice.
(C) Relative telomere length of age-matched (15- to 24-month-old) G3 animals with and without skin lesions, alopecia, and hair graying.
architecture of hematopoietic organs or in the peripheral not reveal specific causes of death in late generation
mTR null mice (data not shown).blood counts (data not shown). Thus, while telomere
shortening with age directly affected the skin, mTR2/2
mice did not display other phenotypes classically asso- Decreased Body Weight
Body weight in mice typically increases in early andciated with aging.
late postnatal development up to 1 year of age. Older
animals show a terminal decline in body weight, andReduced Longevity
Telomeres shorten during the lifetime of aging humans, there is a positive correlation between body weight and
life span (Goodrick, 1977; Ingram and Reynolds, 1987).but there is no direct correlation between the telomere
length and the life span of different species (e.g., be- Body weights were recorded at weekly intervals in aging
mTR1/1, G1, and G6 mice throughout postnatal develop-tween mouse and humans) or within species of mice
(reviewed in Greider, 1996). Thus, it is not yet clear to ment. During the first 6 months, body weight curves
were superimposable for all groups (Figure 4A). At bothwhat extent telomere shortening might influence aging
and longevity of complex organisms. There was no sig- 10–14 and 15–18 months of age, the average body
weight of the G6 animals was 20%–25% less than earlynificant difference in the survival of G1 and G3 animals
compared to mTR1/1 controls (Figure 3). In contrast, a generation mTR2/2 and mTR1/1 animals (Figure 4A, p ,
0.0001). Consistent with the decrease in body weight,15% increase in the incidence of spontaneous death
was observed in 3- to 12-month-old G4–G6 animals. a diminished fat cell layer between the dermis and the
skeletal muscles was seen in the skin sections of oldFurther, at older ages, G6 mice showed elevated mortal-
ity. The survival curves of .12-month-old G4 and G5 G6 animals (Figure 1F, asterisk), a finding considered
to be a typical feature of aged human skin (Zivicnjak etanimals paralleled those of mTR1/1 and G1–G3 animals,
while G6 mice died earlier. The 50% mortality mark oc- al., 1997). In the gastrointestinal tract, villous atrophy
and zonal blunting in the proximal intestine were de-curred at 18 months for G6 mice, while 50% mortality
was not reached until 24 months for mTR1/1 and G1–G4 tected in a subset (3/5) of the aged G6 animals by whole-
mount staining and histological sections (Figures 4B–4E,mice. As is often the case in natural death in humans,
macroscopic and histological analyses at autopsy did representative samples shown). This disruption of the
Table 1. Summary of Phenotypic Analysis in Aging Mice
mTR1/1 G3 mTR2/2 G6 mTR2/2
Body weight Normal Normal 20%–25% decreased in .6-month-old mice
Diabetes Normal GTT Normal GTT Normal GTT
Osteoporosis Normal X-ray Normal X-ray Normal X-ray
Artherosclerosis None None None
Peripheral RBC & WBC counts Normal Normal Normal
Blood chemistry Normal profile Normal profile Normal profile
Cataract 15% 20% 10%
Male fecundity 12–15 months 6.5 months Normally infertile, rarely successful in
generating offspring
Hair graying and alopecia 25% 54% 60%
Skin histology Normal Decrease of hair follicles in anagen, Decrease of hair follicles in anagen, increase
increase in telogen in telogen, loss of subcutaneous fat
Ulcerative skin lesions 10% 31% 37%
Wound healing Normal Delayed reepithelilization Delayed reepithelialization
Cancer incidence 3.3% 13% 19%
Life span (50% mortality mark) 24 months 24 months 18 months
Aging in the Telomerase Null Mouse
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Figure 3. Loss of Telomere Ends Correlates with a Shortened Life
Span
Survival curves of mTR1/1, G1, G2–3, G4–5, and G6 mice, with per-
cent of surviving animals plotted at 3-month intervals.
normal villous architecture is likely to contribute directly
to body weight loss due to decreased nutritional absorp-
tion, an observation that has been described for aging
rodents (Keelan et al., 1985; Chen et al., 1990).
Impaired Stress Response in Aged mTR2/2 Mice
The limitation of cell replication by telomere shortening
could affect the ability of the aging organism to respond
to pathological conditions that provoke elevated cell
turnover, as for example wounding, chronic hemolysis/
bleeding, or infection. To address this possibility more
directly, wound healing studies and the recovery poten-
tial of the hematopoietic system following blood cell
ablation with 5-fluorouracil (5-FU) were monitored in
young (1–3 months) and old (15–20 months) mTR1/1,
G3, and G6 mice.
Wound Healing
Four 3 mm punch biopsies were performed on the skin
of the scapulae of mice housed in isolation, and the rate
of wound healing was monitored by gross inspection
and by serial histological examination. One day after
wounding (PWD 1), the wounds of 15- to 18-month-old
G3 and G6 mice exhibited delayed coagulum formation
and remained opened and wet, while age-matched G1
and mTR1/1 mice achieved complete coagulum forma- Figure 4. Reduced Body Weight and Villi Atrophy of the Small Intes-
tion over all wounds (data not shown). The delay in tine in Aged G6 mTR2/2 Mice
wound closure was most apparent when wounds of (A) Body weights in mTR1/1 and mTR2/2 mice plotted as a function
PWD 4 and PWD 6 were compared, where day 6 wounds of age. Old G6 animals showed 20%–25% decrease in body weights.
(B and C) H&E-stained cross sections of mTR1/1 and G6 duodenumin the old G3 and G6 animals appeared macroscopically
at 18 months of age, showing blunted, markedly atrophic villi (203equivalent in size to day 4 wounds in age-matched G1
objective).and mTR1/1 (Figures 5A and 5B, compare mTR1/1 day 4
(D and E) Whole-mount preparations of mTR1/1 and G6 duodenum
to G6 day 6; G1 and G3 not shown). Histological sections stained with methylene blue. Prominent areas of disorganized villi
through the healing wounds revealed a marked delay in are present in the G6 duodenum (arrows).
wound reepithelialization in the old G3 and G6 mice
(Figures 5C and 5D, G3 wounds not shown). Reepitheli-
alization of wounds takes place by migration of keratino- animals, respectively. The two epithelial gaps present in
old mTR1/1 animals possessed a mean gap diameter ofcytes from the wound edge toward the center and is
known to be impaired in aged mice and humans (Holt 240 mm. On average, the 15- to 18-month-old G3 and
G6 mice required an additional 2 days to achieve fullet al., 1992; Ashcroft et al., 1997a, 1997b). In the older
group of mice 2/16 (13%), wounds in mTR1/1 mice dis- reepithelialization (6 versus 4 days for controls). It is
interesting to note that, despite comparably short telo-played incomplete reepithelialization at PWD 4, com-
pared to 4/12 (33%) in G1, 7/10 (70%) in G3, and 12/16 meres in old G3 and young G6 mice, impaired wound
healing is observed only in aged mTR2/2 possessing(75%) in G6 mice (p 5 0.001). On PWD 4, epithelial gap
diameters averaged 2097 and 2378 mm in old G3 and G6 critically shorter telomeres and accompanying telomere
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Figure 5. Delayed Wound Healing in Aged mTR2/2 Mice
(A) Gross appearance of healing wounds of mTR1/1 and G6 mice 4 and 6 days after wounding (23 objective).
(B) Wound areas at day 0 and 6 post wounding.
(C and D) Midtransverse sections (5 mm) through healing skin wounds at day 4 post wounding (H&E). Near complete reepithelilization was
detected in mTR1/1 controls, in contrast to the prominent epithelial gap seen in G6 wounds (403 objective).
dysfunction (e.g., chromosomal fusions). Although the platelets not shown). Similarly, body weight curves
showed a marked decline only in the old mice followingmechanistic basis for impaired wound healing is not
well understood and thought to involve an interplay of 5-FU injection. Loss of body weight, which serves as an
indicator of gastrointestinal defects and overall fitness,cellular proliferation, growth factor production, and im-
mune system dysfunction, the absence of significant was more pronounced in old G6 compared to old
mTR1/1, while G3 animals exhibited an intermediatedifferences in BrdU incorporation (data not shown) indi-
cates that the impact of telomere shortening in wound phenotype (average loss of body weight 15% and 10%,
respectively). The clinical appearance of the old G3 andrepair of the aged mTR2/2 mice is complex and extends
beyond simple proliferation defects. G6 animals was markedly compromised, and subcuta-
neous injections of saline to maintain hydration of the
animals had no therapeutic benefit. As a consequenceResponse to Blood Cell Depletion
To further examine the capacity to cope with acute of this generalized morbidity, three out of four old G6
and two out of five old G3 animals died on days 6–11.stress, peripheral blood cell kinetics and survival follow-
ing 5-FU-induced ablation of the hematopoietic system Notably, the mice that succumbed were those that
showed the most profound decrease in WBC countswere monitored in young and old mTR1/1 and mTR2/2
mice. mTR1/1 mice will typically recover from a low dose (specifically neutropenia) and body weight. In contrast,
all of the old mTR1/1 animals regenerated WBC countsof 5-FU (100 mg/kg body weight i.p.), and the ability to
regain peripheral blood counts and body weight after by day 11, regained pretreatment body weights, and
survived the treatment protocol. Red blood cells de-5-FU injection is a measure of the ability of the mice to
respond to the induced stress. 5-FU exposure had no creased in all treated animals (in part due to repeated
phlebotomy for the peripheral blood count determina-significant effect on body weight, WBC, hemoglobin,
and the overall clinical status of young animals in all tions); nevertheless, a delay in renewal was observed
in old G3 and G6 but not in the mTR1/1 or youngermTR2/2 generations (Figures 6A–6C). In contrast, older
mice (16–22 months) showed a decline in all peripheral cohorts. Whereas three out of four old mTR1/1 animals
had regained sufficient hemoglobin levels (.10 g/dl) byblood cells with the lowest point occuring 6 days after
injection (Figure 6B, WBC; Figure 6C, hemoglobin levels; day 11 after treatment, four out of five G3 and G6 animals
Aging in the Telomerase Null Mouse
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Figure 6. Age and Telomere Shortening Cooperate to Diminish Hematopoietic Reserve
Stress response to 5-FU treatment in young (2–3 months) and old (16–24 months) mTR1/1, G3, and G6 mice.
(A) Body weight, (B) peripheral WBC, and (C) hemoglobin levels (g/dl) plotted against days after 5-FU treatment; all parameters showed a
dramatic reduction 6 days after treatment in old but not in young animals, with eventual recovery in mTR1/1 animals. Asterisks indicate animal
death: 0/4 in mTR1/1, 2/5 in G3, and 3/4 in G6 mice.
Cell
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Figure 7. Genomic Instability and an Increased
Incidence of Spontaneous Cancer in Aging
mTR2/2 Mice
(A and B) Representative metaphase spreads
of lymphocytes. Circled area in (B) denotes
chromosomal p-arm fusion in old G3 mouse.
(C) Incidence of macroscopically visible and
clinically apparent spontaneous cancers.
(D) Age of onset of spontaneous cancers.
(E) Histological classification of spontaneous
tumors.
(F) Cytogenetic analysis of representative
spontaneously arising tumors.
(G) Telomere length in splenocytes of 18-
month-old WT and G6 mice, and in teratocar-
cinomas and lymphomas derived from WT
and mTR2/2 mice. A human telomerase posi-
tive cervical carcinoma cell line (HeLa) is in-
cluded for comparison of telomere lengths.
still showed critically low hemoglobin levels (,7 g/dl) contribute to the increase in phenotypic abnormalities.
To examine this possibility, metaphase spreads were(Figure 6C). Together these results demonstrate a di-
minished capacity of the aged telomerase-deficient prepared from mitogen-stimulated peripheral white blood
cells and splenic lymphocytes of young and old mTR1/1mice to respond to a stress known to challenge the
regenerative potential of the hematopoietic and gastro- and G3 mice. No chromosomal fusions were observed
in .30 metaphases derived from 2- to 3-month-oldintestinal systems.
mTR1/1 (data not shown) and G3 mice (Figure 7A).
In .15-month-old G3 animals, an increased frequencyIncreased Cytogenetic Abnormalities in Aged Late
Generation mTR2/2 Mice of chromosomal fusions occurred (Figure 7B). While fu-
sions in mTR1/1 animals were rare and seen only inLoss of telomere function in the mTR null mouse is
associated with an increase in the frequency of chromo- animals older than 24 months of age (frequency: 0.14
fusions per metaphase), chromosomal fusions weresomal fusions and aneuploidy (Blasco et al., 1997; Lee
et al., 1998). Since the studies described above demon- seen at a frequency of 0.45 fusions per metaphase in
G3 mice older than 15 months. The increased incidencestrated telomere loss as a function of age, it was possi-
ble that an increase in genomic instability with age could in chromosomal fusions with increasing age in the
Aging in the Telomerase Null Mouse
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mTR2/2 mice is consistent with the observation that exhibit progressive telomere shortening and loss of pro-
mTR2/2 cell lines exhibit 50-fold more chromosomal fu- liferative cell types with each progressive generation
sions than mTR1/1 cell lines under similar passage con- (Blasco et al., 1997; Lee et al., 1998). Here we find that
ditions (Hande et al., 1999). the ability of the mTR2/2 mice to respond to various
physiological stresses is compromised and declines
Progressive Increase in the Rate of Spontaneous with increasing age of the mouse. The mTR2/2 mouse
Tumor Formation in Successive Generations may be a good model for the age-associated decline
of mTR2/2 Mice in certain organ systems, particularly with regard to a
Telomere loss and resultant chromosomal fusions can hallmark feature of aging—a reduced capacity to toler-
be consequences of cell growth and selection during ate acute stress. In addition, the increased tumor forma-
tumorigenesis but may also play a role in increased tion in the aging mTR2/2 colony suggests that loss of
cancer incidence in aging populations as speculated telomere function may initiate genetic instability.
previously (Hastie et al., 1990; de Lange, 1995). The
increase in chromosomal fusions in successive genera-
Telomere Length, Cellular Senescence,tions of young mTR null mice (G4 onward) and the age-
and Life Spandependent increase in chromosomal fusions in periph-
The correlation of telomere length and cellular senes-eral blood leukocytes of non–tumor-bearing aged G3
cence in human cells suggested that telomeres maymice provided an opportunity to assess the role of loss
somehow signal entry into cellular senescence in tissueof telomere function in cancer incidence. We monitored
culture (Harley et al., 1990; Allsopp et al., 1992). Recentan aging population of mTR1/1 and successive genera-
experiments have provided significant support for thistions of mTR2/2 mice for visible tumors. The tumors
model (Bodnar et al., 1998; Vaziri and Benchimol, 1998;from both mTR1/1 and mTR2/2 mice were confirmed
reviewed in Greider, 1998). The role of both cellular se-malignant by histological analysis. There was a 4- to
nescence and telomere length in aging is less clear.6-fold increase in the incidence of spontaneous cancers
Many of the phenotypic consequences of in vitro cellularin mTR2/2 animals (Figure 7C, p 5 0.01, compare mTR1/1
senescence are seen in aging tissue in vivo (Stanulis-to G4–G6). Although the absolute number of tumors
Praeger, 1987; Campisi, 1997). However, given that lifewas low, it is noteworthy that the average age at tumor
span determination likely has multiple inputs, it is not yetformation was younger in G4–G6 mice compared to
clear what role cellular senescence plays in determiningmTR1/1 and G1–G3 mice (20.5 versus 26.3 months, re-
organismal life span. While telomere length correlatesspectively, p 5 0.04; Figure 7D). In addition, the cancer
well with cellular senescence, there is no evidence forrate in later generations (G4–G6) is higher than in G1–G3,
even though many G6 mice have yet to reach an equiva- a clear correlation at the organismal level with human life
lently old age, during which the highest cancer rates span. Further, mouse telomeres are significantly longer
were observed for mTR1/1 and G1–G3 animals. (Thus, than human telomeres, and species differences in telo-
the cancer incidence reported here is likely to be an mere length in the mouse do not correlate with life span
underestimate for the G4–G6 cohort.) The majority of (Greider, 1996). Thus, to the extent that there is a similar
tumor types originate from highly proliferative cell types mechanism of life span determination between these
(i.e., teratocarcinomas [germ cells], lymphomas [leuko- two species, it is unlikely that telomere length is the
cytes], and squamous cell carcinomas [keratinocytes]). driving determinant. Although some aspects of the
These cell types are likely to sustain the highest degree mTR2/2 mouse mimic age-associated disease, many
of telomere shortening with increasing age (Figure 7E). signs and symptoms classically associated with prema-
Together, these findings are consistent with the hypoth- ture aging mouse models were not evident in mTR2/2
esis that loss of telomere function and the resulting mice. In particular, there was no evidence of increased
genetic instability that ensues facilitate the development cataract formation, osteoporosis, glucose intolerance,
of certain cancers. In line with this hypothesis, cytoge- or vascular disease. However, the decreased stress re-
netic analysis of the tumors showed a 3- to 18-fold sponse seen in the mTR2/2 mouse provides a good
increase in the number of chromosomal fusions per model to study the role of the age-related decline in
metaphase and a 2-fold increase in the incidence of stress response seen in humans.
aneuploidy in mTR2/2 tumors compared to mTR1/1 tu-
mors (Figure 7F). Although only two mTR1/1 tumors were
Impaired Telomere Function and Stress Responseexamined in this study, the low incidence of chromo-
The aged, late generation mTR2/2 mice showed dimin-somal fusions detected in these tumors was also ob-
ished response to stress in several different settings.served in mTR1/1 tumors derived from the Ink4a2/2 mice
This decreased stress response could be a direct result(Greenberg and R. A. D., unpublished data). Flow-FISH
of the decline in proliferative capacity of specific cellanalysis revealed shorter telomere ends in late genera-
types or could indicate a more global organismal re-tion mTR2/2 tumors compared to mTR1/1 tumors and
sponse to telomere shortening. Although studies fromearly generation mTR2/2 tumors (Figure 7G), indicating
yeast show that telomere shortening only manifests it-that loss of telomere function might contribute to tumori-
self after many cell divisions, the work presented heregenesis in these animals.
suggests that under some circumstances in mice, phe-
notypes can be observed that are not directly relatedDiscussion
to cell division. The inability of B and T cells from mTR2/2
animals to respond to mitogenic stimulation is apparentTelomere and chromosome stability is necessary for cell
viability. Previous studies showed that the mTR2/2 mice in the first cell cycle after a mitogen is provided (Lee et
Cell
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al., 1998). Since this phenotype can already be seen in At face value, the increased tumor incidence seems to
G3 animals, and yet G4–G6 animals have viable B and contradict the decrease in tumor formation expected
T cells, the lack of response to mitogens cannot simply from the loss of cell viability associated with telomere
be due to reaching a critically short telomere length dysfunction. It also appears confusing in light of the
or a limit to cell division capacity. In a similar fashion, frequent upregulation of telomerase postcrisis (Harley
although the decreased response to stress described and Sherwood, 1997; Shay, 1997) or the ability of telo-
in this paper might be due in part to a diminished cell merase to facilitate transit through crisis (Counter et al.,
renewal capacity, it is also possible that short telomeres 1992; de Lange, 1994; Weinberg, 1998). Moreover, we
may directly impact upon more differentiated functions in have documented a significant decrease in tumor inci-
certain tissues (e.g., cytokine production, signaling, etc.). dence in mice doubly null for mTR2/2 (G4 onward) and
As individuals age, although baseline organ function the INK4a tumor suppressor gene (Greenberg and
remains adequate to sustain a healthy state, aged or- R. A. D., unpublished data). The difference in these stud-
gans exhibit a markedly diminished capacity to cope ies may be that in early divisions loss of telomere func-
with diverse acute and chronic stresses (Jazwinski, tion can initiate genetic instability, while at later points
1996). Impaired lymphocyte responsiveness in acute in- in tumor progression the absence of telomerase inhibits
fections or diminished epithelial repair leading to chronic long-term growth. Thus, while telomerase inhibition may
skin ulcers is often seen in aging individuals (Jurivich et be a valid approach in the treatment of established tu-
al., 1997). Similarly, increased mortality and morbidity mors, age-dependent telomere shortening may be an
are evident following physiological stresses associated important risk factor for cancer in settings of bypass
with chemotherapy or general surgery (Haeney, 1994). of the mortality I checkpoint. Together, these studies
Although the mechanisms for how short telomeres block underscore the complex relationship between telomeres,
cell division and trigger apoptosis without ongoing cell tumorigenesis, and aging and highlight the need to con-
division are not yet known, the mTR2/2 mouse provides duct relevant studies in intact organisms against the
an excellent model to study the possible role of telomere backdrop of defined cancer-relevant mutations.
length in these cellular stress responses at the organis-
mal level. This mouse model may thus shed light on this Experimental Procedures
very important aspect of aging. Specifically, since the
stress responses observed in old mTR1/1 and G1 mice mTR Null Mouse and Mating Scheme
Production of the mTR null mouse has been described previouslywere similar to those seen in young G6 mice, the aged
(Blasco et al., 1997). Generation 1 (G1) knockout animals and mTR1/1late generation mTR2/2 mouse may provide an in vivo
control animals were derived from heterozygous intercrosses (mixedsystem to model age-related decline of gastrointestinal,
genetic background). Mating of G1-mTR2/2 animals to each otherhematopoietic, and cutaneous systems of humans.
generated G2 animals. Following this mating scheme, mTR2/2 ani-
mals up to the sixth generation (G6) were produced. All animals
Genetic Instability and Increased Cancer Incidence were kept in the same room and fed ad libidum. Routine serologies
in Aging mTR2/2 Animals confirmed that all mice remained pathogen free over the entire study
period.One of the functions of the telomere is to protect chro-
mosomal ends from fusions and other rearrangements.
Alopecia and Hair GrayingPrevious studies employing human fibroblasts have es-
Hair graying was quantitated at different parts of the animal’s bodytablished a correlation between a progressive decline
by estimating the percentage of gray hairs, and the results were
in telomere length during passage and an increased classified as either mild (,10%), medium (10%–30%), or severe
incidence of telomere fusions (Counter et al., 1992; Vaziri (.30%) hair graying. Alopecia was quantitated by counting hairs in
et al., 1993). Similarly, a reduction in telomere length in one square centimeter areas of the animal’s back (Courtois et al.,
1995). Quantification of hair follicles in the telogen or anagen phasesuccessive generations of mTR null mice is associated
of hair growth was performed on hematoxylin and eosin (H&E)with Robertsonian end-to-end fusions (Blasco et al.,
stained cross sections of the animal’s dorsal skin.1997; Lee et al., 1998). The fact that telomeres are short-
ened in a variety of human cancers in which chromo-
Skin Analysis and Wound Healing Studies
somal abnormalities are also commonly present has fu- Four 3 mm full thickness punch biopsies extending through the
eled speculation that telomere erosion might be a risk epidermis and dermis to the panniculus carnosus were made overly-
factor for the genesis of some tumors (Pathak et al., ing the scapulas using circular skin bioptomies. Wounds were cre-
ated in four different animals per group (2- to 3-month and 15- to1994; de Lange, 1995).
18-month-old mTR1/1, G1, G3, and G6) after chemical depilation.We found a correlation between an age- and genera-
Wound sizes were measured with a 23 objective. At 4 and 6 daystion-dependent increase in cytogenetic abnormalities
after wounding, 5 mm midtransverse paraffin sections were stained(consistent with telomere dysfunction, e.g., end-to-end
with H&E. Epithelial gap diameters were determined by optical mi-
fusions) and an increase in the incidence of spontaneous crometer measurements using calibrated 103 and 203 objectives
cancers. This link is supported by the earlier age of onset at post wounding day 4.
of tumors in the later generations and by the spectrum
of cancer types and their emergence from telomere- 5-Fluorouracil Study
Two-month and 16- to 20-month-old mTR1/1, G3, and G6 animalsdependent organs (lymphoid, testes, and skin; testis
were treated with an i.p. bolus injection of 5-fluorouracil (5-FU) atnot shown). Particularly striking is the high incidence
a dose of 100 mg/kg body weight. Peripheral blood was obtainedof teratocarcinomas in the mTR2/2 mice in light of the
via tail bleeds before injection and on days 6 and 11 after injection.
extremely low incidence of such tumors in our large Bleeding was terminated upon withdraw of 150 ml blood volume.
mTR1/1 mouse colony over many years. Such a correla- Peripheral blood counts and white blood cell differentials were ana-
tion is consistent with the hypothesis that telomere ero- lyzed by an automated CBC analyzer and by microscopic exami-
nation.sion may initiate genetic instability that leads to cancer.
Aging in the Telomerase Null Mouse
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Gastrointestinal Tract and Overall Organ Assessments and their receptors in a murine incisional model. J. Anat. 190,
351–365.Whole-mount staining of the intestine was performed on 1 cm2 prep-
arations as described previously (Pretlow et al., 1991). For histology, Ashcroft, G.S., Horan, M.A., and Ferguson, M.W. (1997b). Aging is
the organs were fixed in 10% formalin, and 5 mm paraffin sections associated with reduced deposition of specific extracellular matrix
were stained with H&E. Serum analysis for LDH, bilirubin, AST, ALT, components, an upregulation of angiogenesis, and an altered in-
total protein, albumin, alkaline phosphatase, GGT, and cholesterol, flammatory response in a murine incisional wound healing model.
uric acid, creatinine, calcium, and serum electrolytes was analyzed J. Invest. Dermatol. 108, 430–437.
using a DAX analyzer. Glucose tolerance tests (2 mg glucose/g Austriaco, N.R., and Guarente, L.P. (1997). Changes of telomere
body, i.p.) were performed after a 16 hr fast on mTR1/1, G3, and G6 length cause reciprocal changes in the life span of mother cells in
animals. Bone density radiographs were taken on dissected mouse Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 94, 9768–
femurs of 2- to 3-month-old and 18- to 24-month-old mTR1/1, G3, 9772.
and G6 animals (three different animals per group) using AD Mammo Blasco, M.A., Lee, H.W., Hande, M.P., Samper, E., Lansdorp, P.M.,
Fine film (Fuji). DePinho, R.A., and Greider, C.W. (1997). Telomere shortening and
tumor formation by mouse cells lacking telomerase RNA. Cell 91,
Telomere Length Analysis 25–34.
Telomere length analysis was performed on peripheral white blood Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C.P., Morin,
cells by flow-cytometry-FISH as recently described (Hultdin et al., G.B., Harley, C.B., Shay, J.W., Lichsteiner, S., and Wright, W.E.
1998; Rufer et al., 1998). Peripheral blood cells were obtained after (1998). Extension of life-span by introduction of telomerase into
tail bleeds (500 ml) and red cell lysis with ammonium chloride. Day normal human cells. Science 279, 349–352.
to day variations in the linearity of the flow cytometer were controlled
Campisi, J. (1997). The biology of replicative senescence. Eur. J.
by the use of FITC-labeled fluorescence beads (Flow Cytometry
Cancer 33, 703–709.
Standards Corporation, San Juan, Puerto Rico).
Campisi, J. (1998). The role of cellular senescence in skin aging. J.
Investig. Dermatol. Symp. Proc. 3, 1–5.
Metaphase Spreads
Chang, E., and Harley, C.B. (1995). Telomere length and replicativeSplenocytes and peripheral blood cells were stimulated with mito-
aging in human vascular tissues. Proc. Natl. Acad. Sci. USA 92,gens (5 mg ConA/ml 1 LPS [100 mg/ml]) for 24 hr followed by incuba-
11190–11194.tion in 0.1 g/ml colcemid for 60 min. Tumor cells were treated for
Chen, T.S., Currier, G.J., and Wabner, C.L. (1990). Intestinal transport1–4 hr with colcemid, depending on the growth characteristics. After
during the life span of the mouse. J. Gerontol. 45, 129–133.spinning at 1000 rpm, the cells were incubated in 75 mmol KCl for
15 min, spun again, and fixed in methanol:glacial acetic acid (3:1, Cooke, H.J., and Smith, B.A. (1986). Variability at the telomeres of
v:v). Metaphases were dropped from 1 m onto frosted microscope the human X/Y pseudoautosomal region. Cold Spring Harb. Symp.
slides positioned at a 458 angle. Giemsa staining was performed Quant. Biol. 51 Pt 1, 213–219.
according to standard protocols. Quantification of fusions and pho- Counter, C.M. (1996). The roles of telomeres and telomerase in cell
tographs were taken with 603 and 1003 objectives. life span. Mutat. Res. 366, 45–63.
Counter, C.M., Avilion, A.A., LeFeuvre, C.E., Stewart, N.G., Greider,
Cancer Incidence C.W., Harley, C.B., and Bacchetti, S. (1992). Telomere shortening
Aging mice were inspected weekly for macroscopically visible tu- associated with chromosome instability is arrested in immortal cells
mors or palpable abdominal tumors. Tumor-bearing mice were which express telomerase activity. EMBO 11, 1921–1929.
anesthezised, and tumor biopsies were taken for histology and Courtois, M., Loussouarn, G., Hourseau, C., and Grollier, J.F. (1994).
metaphase preparations. All cancer diagnoses were confirmed his- Hair cycle and alopecia. Skin Pharmacol. 7, 84–89.
tologically. Animals that were found dead were dissected and in-
Courtois, M., Loussouarn, G., Hourseau, C., and Grollier, J.F. (1995).spected for macroscopically visible tumors.
Ageing and hair cycles. Br. J. Dermatol. 132, 86–93.
de Lange, T. (1994). Activation of telomerase in a human tumor.Statistics
Proc. Natl. Acad. Sci. USA 91, 2882–2885.Unpaired t test and Fisher’s exact test were used for calculation of
de Lange, T. (1995). Telomere dynamincs and genomic instabilityp values.
in human cancer. In Telomeres, E.H. Blackburn and C.W. Greider,
eds. (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press),Acknowledgments
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